Published in J Clin Psychopharmacol on February 01, 2009
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry (2011) 5.46
The promise and reality of pharmacogenetics in psychiatry. Psychiatr Clin North Am (2010) 0.92
Association of genetic variants of the histamine H1 and muscarinic M3 receptors with BMI and HbA1c values in patients on antipsychotic medication. Psychopharmacology (Berl) (2011) 0.83
Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents. Psychiatr Genet (2009) 0.82
Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications. Pharmacogenomics (2011) 0.79
The role of leptin in antipsychotic-induced weight gain: genetic and non-genetic factors. J Obes (2012) 0.78
Genetic Determinants of Clozapine-Induced Metabolic Side Effects. Can J Psychiatry (2016) 0.75
Genetics of Common Antipsychotic-Induced Adverse Effects. Mol Neuropsychiatry (2016) 0.75
Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid. Int J Neuropsychopharmacol (2015) 0.75
A Novel Drug-Mouse Phenotypic Similarity Method Detects Molecular Determinants of Drug Effects. PLoS Comput Biol (2016) 0.75
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry (2011) 5.46
Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med (2008) 4.79
The risk of cancer in users of statins. J Clin Oncol (2004) 3.01
A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf (2002) 2.98
Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry (2011) 2.75
Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer. J Clin Oncol (2010) 2.61
Safety-related regulatory actions for biologicals approved in the United States and the European Union. JAMA (2008) 2.33
VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation. Clin Pharmacol Ther (2006) 2.19
Depressive symptoms in subjects with diagnosed and undiagnosed type 2 diabetes. Psychosom Med (2007) 2.09
Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. J Clin Psychiatry (2005) 1.80
Smart sensors to network the world. Sci Am (2004) 1.77
Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med (2004) 1.76
Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project. Curr Clin Pharmacol (2014) 1.73
Frequency and nature of drug-drug interactions in a Dutch university hospital. Br J Clin Pharmacol (2009) 1.71
Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens (2005) 1.58
A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder. J Clin Psychiatry (2004) 1.57
Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol (2007) 1.55
Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder. Prostaglandins Leukot Essent Fatty Acids (2009) 1.54
The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study. J Am Med Inform Assoc (2009) 1.52
Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail (2003) 1.50
Generic substitution of antihypertensive drugs: does it affect adherence? Ann Pharmacother (2005) 1.47
Antipsychotic drug use and risk of pneumonia in elderly people. J Am Geriatr Soc (2008) 1.46
The effect of computerized physician order entry on medication prescription errors and clinical outcome in pediatric and intensive care: a systematic review. Pediatrics (2009) 1.45
Initiation of antidepressant therapy: do patients follow the GP's prescription? Br J Gen Pract (2009) 1.42
Unpredictable bias when using the missing indicator method or complete case analysis for missing confounder values: an empirical example. J Clin Epidemiol (2010) 1.42
Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies. Clin Pharmacokinet (2010) 1.41
The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol (2008) 1.40
Effects of controlled discontinuation of long-term used antipsychotics on weight and metabolic parameters in individuals with intellectual disability. J Clin Psychopharmacol (2013) 1.38
A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder. J Clin Psychopharmacol (2003) 1.36
No increased incidence of diabetes in antidepressant users. Int Clin Psychopharmacol (2007) 1.33
Drug-induced immune thrombocytopenia. Drug Saf (2004) 1.32
Signal selection and follow-up in pharmacovigilance. Drug Saf (2002) 1.32
Effect of medication reconciliation with and without patient counseling on the number of pharmaceutical interventions among patients discharged from the hospital. Ann Pharmacother (2009) 1.26
Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review. Drugs Aging (2008) 1.26
Incidence and determinants of long-term use of antidepressants. Eur J Clin Pharmacol (2004) 1.25
Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother (2005) 1.23
Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients. Arch Intern Med (2003) 1.23
Patient risk profiles and practice variation in nonadherence to antidepressants, antihypertensives and oral hypoglycemics. BMC Health Serv Res (2007) 1.16
The relationship between study characteristics and the prevalence of medication-related hospitalizations: a literature review and novel analysis. Drug Saf (2010) 1.16
Determinants of the range of drugs prescribed in general practice: a cross-sectional analysis. BMC Health Serv Res (2007) 1.16
Evaluation of the clinical value of pharmacists' modifications of prescription errors. Br J Clin Pharmacol (2004) 1.10
Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions. Drug Saf (2006) 1.10
Phenoconversion of cytochrome P450 2D6: the need for identifying the intermediate metabolizer genotype. J Clin Psychiatry (2013) 1.08
Linking laboratory and medication data: new opportunities for pharmacoepidemiological research. Clin Chem Lab Med (2007) 1.08
A Dutch guideline for the use of clozapine. Aust N Z J Psychiatry (2010) 1.08
Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med (2002) 1.07
Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophr Res (2010) 1.06
Association between antidepressant drug use and hyponatraemia: a case-control study. Br J Clin Pharmacol (2002) 1.06
Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int J Neuropsychopharmacol (2010) 1.05
Glutamate and anxiety. Eur Neuropsychopharmacol (2004) 1.05
Represcription after adverse drug reaction in the elderly: a descriptive study. Arch Intern Med (2006) 1.04
The effect of pharmacotherapy audit meetings on early new drug prescribing by general practitioners. Ann Pharmacother (2007) 1.03
A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry (2004) 1.03
A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol Psychiatry (2004) 1.03
Refill persistence with chronic medication assessed from a pharmacy database was influenced by method of calculation. J Clin Epidemiol (2005) 1.03
The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen. J Hypertens (2004) 1.03
The relationship between benzodiazepine use and traffic accidents: A systematic literature review. CNS Drugs (2010) 1.00
An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces. Int J Neuropsychopharmacol (2011) 0.99
Lithium use and the risk of fractures. Bone (2006) 0.99
Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder. Psychiatry Res (2004) 0.98
The prevalence and incidence of medicinal cannabis on prescription in The Netherlands. Eur J Clin Pharmacol (2013) 0.96
Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: towards individualized dosing. Clin Pharmacokinet (2012) 0.96
Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study. Value Health (2011) 0.96
Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: association with the metabolic syndrome in patients? Schizophr Res (2008) 0.95
Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome. Psychoneuroendocrinology (2012) 0.95
Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum. Bioanalysis (2009) 0.95
Characteristics and reasons associated with nonacceptance of selective serotonin-reuptake inhibitor treatment. Ann Pharmacother (2007) 0.95
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005). Pharmacoepidemiol Drug Saf (2007) 0.95
The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial. J Clin Psychopharmacol (2017) 0.94
Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. J Clin Epidemiol (2009) 0.93
Reliability of the assessment of preventable adverse drug events in daily clinical practice. Pharmacoepidemiol Drug Saf (2008) 0.93
Symptom dimensions in obsessive-compulsive disorder: factor analysis on a clinician-rated scale and a self-report measure. Psychopathology (2004) 0.93
Clinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord (2012) 0.92
Valproic acid-induced hair-texture changes in a white woman. Epilepsia (2007) 0.92
The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia. J Clin Psychopharmacol (2007) 0.92
Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder. Int Clin Psychopharmacol (2003) 0.92
Linking community pharmacy dispensing data to prescribing data of general practitioners. BMC Med Inform Decis Mak (2006) 0.92
An algorithm to identify antidepressant users with a diagnosis of depression from prescription data. Pharmacoepidemiol Drug Saf (2009) 0.91
The effect of the COACH program (Continuity Of Appropriate pharmacotherapy, patient Counselling and information transfer in Healthcare) on readmission rates in a multicultural population of internal medicine patients. BMC Health Serv Res (2010) 0.91
Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: comparison with officially recommended doses. J Clin Psychiatry (2006) 0.91
Spatial working memory deficits in obsessive compulsive disorder are associated with excessive engagement of the medial frontal cortex. Neuroimage (2003) 0.90
Risk of hip/femur fractures in patients using antipsychotics. Bone (2005) 0.90
The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients. J Clin Psychopharmacol (2015) 0.90
The impact of hospitalisation on the initiation and long-term use of benzodiazepines. Eur J Clin Pharmacol (2005) 0.90
HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study. J Clin Psychopharmacol (2009) 0.89
Compliance with national guidelines for the management of drug-drug interactions in Dutch community pharmacies. Ann Pharmacother (2007) 0.89
A high throughput Agrobacterium tumefaciens-mediated transformation method for functional genomics of perennial ryegrass (Lolium perenne L.). Plant Cell Rep (2006) 0.89
Duration of antidepressant drug treatment and its influence on risk of relapse/recurrence: immortal and neglected time bias. Am J Epidemiol (2009) 0.88